Short contact treatment of psoriasis with topical retinoids

Details Short contact treatment of psoriasis with topical retinoids Short contact treatment of psoriasis with topical retinoids

1999-02-12

2000-04-11

MacMillan, Keith D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

A61K 104

Patent

active

060489022

ABSTRACT:
The present invention relates to a method of treating psoriasis using short-term contact with a topically-applied retinoid composition.

REFERENCES:
patent: 5089509 (1992-02-01), Chandraratna
patent: 5516793 (1996-05-01), Duffy
patent: 5650279 (1997-07-01), Nagpal et al.
patent: 5719195 (1998-02-01), Braiman
patent: 5776687 (1998-07-01), Nagpal et al.
Leyden, James J., Emerging Topical Retinoid Therapies, Journal of the American Academy of Dermatology, Apr. 1998, vol. 38, No. 4, pp. S1-S4.
Chandraratna, R., Tazarotene--first of a new generation of receptor-selective retinoids, British Journal of Dermatology 1996, vol. 135, pp. 18-25.
Azelex package insert by Allegan(manufacture), N/A.
Retin-A package insert by Ortho-Derm(manufacture), N/A.
Allergan Tazorac Plaque psoriasis . . . , Tpink sheet: FDC report, vol. 59/25, Jun. 1997.
Tazorac package insert by allergan(manufacture), N/A.
Lavker et al., An Ultrastructural study of the effects of topical tretinoin . . . , vol. 14(6), pp. 773-780, 1992.

Affiliated with

Also associated with

Rating

Short contact treatment of psoriasis with topical retinoids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Short contact treatment of psoriasis with topical retinoids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Short contact treatment of psoriasis with topical retinoids will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1177162